calendar
183 catalysts · 47 phase 2 completion · 34 phase 1 completion · 22 phase 2 initiation · 21 phase 1 2 completion · 18 phase 1 initiation · 13 phase 1 2 initiation
next 91 dayslessmore
MonWedFri
183 catalysts · 47 phase 2 completion · 34 phase 1 completion · 22 phase 2 initiation · 21 phase 1 2 completion · 18 phase 1 initiation · 13 phase 1 2 initiation
Therapy area: Oncology. Indication: Colorectal Cancer, Esophageal Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Non-Small Cell Lung Cancer, Recurrent Head And Neck Squamous Cell Carcinoma, Solid Tumor
Therapy area: Oncology. Indication: Glioblastoma Multiforme (GBM), Glioma, Recurrent Glioblastoma Multiforme (GBM)
Therapy area: Immunology. Indication: Plaque Psoriasis (Psoriasis Vulgaris), Psoriasis
Therapy area: Oncology. Indication: Malignant Neoplasms
Therapy area: Immunology. Indication: Rheumatoid Arthritis
Therapy area: Oncology. Indication: Non-Small Cell Lung Cancer
Therapy area: Oncology. Indication: Adenocarcinoma, Colon Cancer, Colorectal Cancer
Therapy area: Oncology. Indication: Breast Cancer, Castration-Resistant Prostate Cancer (CRPC), Epithelial Ovarian Cancer, Fallopian Tube Cancer, Metastatic Breast Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Peritoneal Cancer, Solid Tumor
Therapy area: Genito Urinary System, Immunology. Indication: End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), Kidney Transplant Rejection
Therapy area: Oncology. Indication: Glioblastoma Multiforme (GBM), Gliosarcoma
Therapy area: Oncology. Indication: Colorectal Cancer, Metastatic Colorectal Cancer
Therapy area: Oncology. Indication: Adenocarcinoma Of The Gastroesophageal Junction, Gastric Cancer
Therapy area: Immunology, Respiratory. Indication: Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease), Systemic Sclerosis (Scleroderma)
Therapy area: Oncology. Indication: Lung Adenocarcinoma, Non-Small Cell Lung Cancer
Therapy area: Oncology. Indication: Breast Cancer, Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer)
Therapy area: Dermatology, Gastrointestinal, Immunology. Indication: Inflammation, Inguinal Hernia, Wounds
Therapy area: Oncology. Indication: Triple-Negative Breast Cancer (TNBC)
Therapy area: Cardiovascular, Oncology. Indication: Hepatocellular Carcinoma, Thrombosis, Venous (Vein) Thrombosis
Therapy area: Cardiovascular, Oncology. Indication: Diffuse Large B-Cell Lymphoma, Hematological Tumor, Leukemia, Lymphoma, Multiple Myeloma (Kahler Disease), Myeloproliferative Disorders, Pulmonary Embolism, Thromboembolic Disease, Venous Thromboembolism
Therapy area: Oncology. Indication: Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer), Triple-Negative Breast Cancer (TNBC)
Therapy area: Oncology. Indication: Mesenchymal Tumor
Therapy area: Genito Urinary System, Immunology. Indication: Delayed Graft Function (DGF), End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
Therapy area: Oncology. Indication: Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer), Metastatic Breast Cancer, Triple-Negative Breast Cancer (TNBC)
Therapy area: Oncology. Indication: Lung Cancer
Therapy area: Oncology. Indication: Endometrial Cancer
Therapy area: Oncology. Indication: Kidney Cancer (Renal Cell Cancer), Metastatic Renal Cell Carcinoma
Therapy area: Oncology. Indication: Soft Tissue Sarcoma
Therapy area: Oncology. Indication: Neuroblastoma
Therapy area: Immunology. Indication: Inflammation
Therapy area: Oncology. Indication: Prostate Cancer
Therapy area: Oncology. Indication: Adenocarcinoma Of The Gastroesophageal Junction, Gastric Cancer
Therapy area: Oncology. Indication: Colorectal Cancer
Therapy area: Oncology. Indication: Small-Cell Lung Cancer